 |
Tubulointerstitial Nephritis as an Extraintestinal Manifestation of Crohn’s Disease CME DisclosuresRelease Date: October 7, 2008; Valid for credit through October 7, 2009 |
| Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
- Tubulointerstitial Nephritis as an Extraintestinal Manifestation of Crohn's Disease
Aoife M. Waters, MD, MRCPI
Mary Zachos, MD, FRCPC
Andrew M. Herzenberg, MD, FRCPC
Elizabeth Harvey, MD, FRCPC
Norman D. Rosenblum, MD, FRCP
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the pathophysiology of Crohn's disease
- Specify common anatomic locations of extraintestinal complications of Crohn's disease
- Identify the medication most implicated in the promotion of tubulointerstitial
nephritis in Crohn's disease
- Describe the treatment and prognosis of tubulointerstitial nephritis in Crohn's disease
Authors and Disclosures Aoife M. Waters, MD, MRCPI
Disclosure: Aoife M. Waters, MD, MRCPI, has disclosed no relevant financial relationships.
Mary Zachos, MD, FRCPC
Disclosure: Mary Zachos, MD, FRCPC, has disclosed no relevant financial relationships. Andrew M. Herzenberg, MD, FRCPC
Disclosure: Andrew M. Herzenberg, MD, FRCPC, has disclosed no relevant financial relationships. Elizabeth Harvey, MD, FRCPC
Disclosure: Elizabeth
Harvey, MD, FRCPC, has disclosed no relevant financial relationships. Norman D. Rosenblum, MD, FRCP
Disclosure:Norman D. Rosenblum, MD, FRCP, has disclosed no relevant financial relationships. Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis,
Inc. Chloe Harman
Disclosure: Chloe Harman has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
